Evaluation of programmed cell death protein 1 (PD-1) expression as a prognostic biomarker in patients with clear cell renal cell carcinoma

Evaluation of programmed cell death protein 1 (PD-1) expression as a prognostic biomarker in patients with clear cell renal cell carcinoma

Programmed cell death protein 1 (PD-1) immune checkpoint inhibitors have shown activity in patients with advanced renal cell carcinoma (RCC). However, the role of PD-1 expression in tumor-infiltrating lymphocytes (TILs) as a biomarker for poor outcome is not clear. In this study, we evaluated the pr...

Full description

Bibliographic Details
Main Authors: Kyu Seo Kim, Rishi R. Sekar, Dattatraya Patil, Michelle A. Dimarco, Haydn T. Kissick, Mehmet A. Bilen, Adeboye O. Osunkoya, Viraj A. Master
Format: Article
Language:English
Published: Taylor & Francis Group 2018-04-01
Series:OncoImmunology
Subjects:
biomarkers
immunotherapy
immunohistochemistry
prognosis
programmed cell death protein 1
pd-1
renal cell carcinoma
Online Access:http://dx.doi.org/10.1080/2162402X.2017.1413519

Internet

http://dx.doi.org/10.1080/2162402X.2017.1413519

Similar Items